Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 158 clinical trials
Featured trial
  • 195 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Randomized, Double-blind, Placebo-controlled, Dose Ranging, Parallel-group Study of the Efficacy and Safety of Plecanatide in Children 6 to less than 18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C)

To evaluate the safety and efficacy of once daily oral plecanatide for 4 weeks as treatment for the relief of symptoms associated with IBS-C in children ages 6 to < 18 years.  

  • 139 views
  • 23 Nov, 2020
  • 1 location
Featured trial
IBS...Irritable Bowel Syndrome

IBS...Irritable Bowel Syndrome

  • 1053 views
  • 08 Nov, 2020
  • 2 locations
Featured trial
Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS)

  • 1928 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Irritable Bowel Syndrome with Diarrhea

Irritable Bowel Syndrome with Diarrhea

  • 804 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Irritable Bowel Syndrome with Constipation (IBS-C)

Irritable Bowel Syndrome with Constipation (IBS-C)

  • 406 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Irritable Bowel Syndrome with Constipation (Synergy Pharmaceuticals)

Irritable Bowel Syndrome with Constipation (Synergy Pharmaceuticals)

  • 80 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Irritable Bowel Syndrome with Constipation Clinical Trial

Irritable Bowel Syndrome with Constipation Clinical Trial

  • 218 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase 3 Clinical Trial for Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

A Phase 3 Clinical Trial for Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

  • 1914 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

  • 644 views
  • 08 Nov, 2020
  • 1 location